Use of Dika Fat in the Formulation of Sustained Release Theophylline Tablets and Capsules
Main Article Content
Abstract
Sustained release theophylline tablets and capsules were prepared with dika fat, a solid vegetable oil extracted from the kernels of Irvingia gabonesis var gabonesis and var excelsia. Anhydrous theophylline was incorporated into dika fat by the fusion method. The in vitro release of the theophylline was monitored by the so-called half change dissolution method in stimulated gastric juice USP without
pepsin and in stimulated intestinal juice without pancreatin, respectively. The USP XX paddle method was used. A level of sustained release was achieved over a 6-h period in both the tabletted and encapsulated dosage forms. The theophylline formulations containing dika fat, prepared in this study, exhibited dissolution profiles similar to those of Theo 24, Theodur and Respid, some commercial sustained release theophylline formulations.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Brossard, C., Lefort de Ylouses, D., Duchene, D., Puisieux, F., Carstensen, J.T. (1983). Dissolution of a soluble drug substance from vinyl plymer matrices. J. Pharm. Sci. 72: 162 – 169.
Conti, S., Maggi, L., Segale, L., OchoaMachiste, E., Conte, U., Grenier, P., Vergnault, G. (2007). Matrices containing NaCMC and HPMC1: Dissolution performance characterization. Int. J. Pharm. 333: 136 - 42
Higuchi, T. (1963). Mechanism of sustained-action medication. Theoritical analysis of rates of release of solid drug dispersed in solid matrices. J. Pharm Sci. 52 (12): 1145 – 1149.
Jambhekar, S.S., Breen, P.J., Rojanassakul, Y. (19870. Influence of formulation and other factors on the release of chlorpheniramine maleate from polymer coated beads. Drug Dev. Ind. Pharm. 13: 2789 - 2810.
Jianhong, L., Shigi, L., Lin, L., Erjia, L. (2005). Release of theophylline from polymer blend hydrogels. IJP 298: 117 – 125.
Karasulu, H.Y., Ertan. G., and Kose, T. (2000). Modelling of theophylline release from different geometrical erodible tablets. Eur. J. Pharm. Biopharm. 49:177 - 182
Khan, G.M. and Zhu, J.B. (1999). Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: Influence of co-excipients on release rate of the drug. J. Contrl. Rel. 57: 197 - 203
(Korsmeyer, RW, Gunny, R, Doelker, E., Buri, P., Peppas, N.A. (1983). Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 15: 25 – 35.
McDaid, F.M., Barker, S.A., Fitzpatrick, S., Petts, C.R. and Craig DQM (2003). Further investigations into the use of high sensitivity differential calorimetry as a means of predicting drug-excipient interactions. Int. J. Pharm. 252: 235 - 40
Onyechi, J. O. (1987), Physico-chemical properties of dika fat and its application in tabletting, Ph.D Thesis, School of Postgraduate studies, University of Nigeria, Nsukka.
Rao, K.V.R., Devi, K.P., Buri, P.. (1988). Swelling controlled release systems: Recent developments and applications. Int. J. Pharm., 48: 1 - 13
Rohera, B.D. and Parikh, N.H. (2002). Influence of the type and level of water soluble additives on drug release and surface and mechanical properties of Surelease films, Pharm. Dev. Technol. 7: 421 – 432.
Saha, R.N., Sajeev, C., and Sahoo, J. (2001). Comparative study of controlled release matrix tablets of diclofenac sodium, ciprofloxacin hydrochloride and theophylline. Drug. Deliv. 8:149 - 154
Semde, R, Amighi, K., Devleeschouwer, M.J., Moes, A.J. (2000). Effect of pectinolytic enzymes on the theophylline release from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate, Int. J. Pharm. 197: 169 – 179.
Tang, L., Schwartz, JB, Porter, SC, Schnaare, RL, Wigent RJ, (2000). Drug release from film coated chlorpheniramine maleate nonpariel beads: effect of water soluble polymer, coating level and soluble core material. Pharm. Dev. Technol. 5:383-390.
Udeala, O.K., Onyechi, J.O. and Agu S.I. (1980). Preliminary evaluation of dika fat a new tablet lubricant. J. Pharm. Pharmacol. 32: 6 -9